ES451015A1 - Ophthalmic inserts - Google Patents

Ophthalmic inserts

Info

Publication number
ES451015A1
ES451015A1 ES451015A ES451015A ES451015A1 ES 451015 A1 ES451015 A1 ES 451015A1 ES 451015 A ES451015 A ES 451015A ES 451015 A ES451015 A ES 451015A ES 451015 A1 ES451015 A1 ES 451015A1
Authority
ES
Spain
Prior art keywords
ophthalmic inserts
ophthalmic
eye
reduction
completely
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES451015A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES451015A1 publication Critical patent/ES451015A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Materials For Medical Uses (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The ophthalmic inserts containing hydroxypropylcellulose as carrier material are particularly effective because they dissolve slowly but completely in water so that they can be used for the production of suitable compositions for prolonged treatment of the eye with, at the same time, a reduction in the dosage frequency.
ES451015A 1973-12-17 1976-08-26 Ophthalmic inserts Expired ES451015A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42542673A 1973-12-17 1973-12-17
US51932374A 1974-10-31 1974-10-31

Publications (1)

Publication Number Publication Date
ES451015A1 true ES451015A1 (en) 1977-08-16

Family

ID=27026681

Family Applications (2)

Application Number Title Priority Date Filing Date
ES432866A Expired ES432866A1 (en) 1973-12-17 1974-12-12 Ophthalmic inserts
ES451015A Expired ES451015A1 (en) 1973-12-17 1976-08-26 Ophthalmic inserts

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES432866A Expired ES432866A1 (en) 1973-12-17 1974-12-12 Ophthalmic inserts

Country Status (25)

Country Link
JP (1) JPS5636173B2 (en)
AT (1) AT333945B (en)
AU (1) AU509331B2 (en)
CA (1) CA1063022A (en)
CH (2) CH609864A5 (en)
DD (2) DD117349A5 (en)
DE (2) DE2459391C3 (en)
DK (1) DK137946B (en)
EG (1) EG11698A (en)
ES (2) ES432866A1 (en)
FI (1) FI58433C (en)
FR (1) FR2254350B1 (en)
GB (2) GB1485150A (en)
HK (1) HK30880A (en)
HU (1) HU171803B (en)
IE (1) IE40466B1 (en)
IL (1) IL46209A (en)
IT (1) IT1056094B (en)
KE (1) KE3049A (en)
LU (1) LU71490A1 (en)
NL (1) NL167326C (en)
NO (1) NO140489C (en)
PH (2) PH10938A (en)
RO (1) RO63070A (en)
SE (1) SE408014B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076942A (en) * 1975-10-01 1978-02-28 Merck & Co., Inc. Crystalline dipilocarpinium pamoate
US4255415A (en) * 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
NZ200429A (en) * 1981-04-30 1984-10-19 Smith & Nephew Ass Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
CH667001A5 (en) * 1985-09-03 1988-09-15 Hugo Degen UNDER MATTRESS.
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
DE19549506C2 (en) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Pharmaceutical or diagnostic dosage form, esp. for ophthalmic use
JP5081413B2 (en) * 2005-07-29 2012-11-28 参天製薬株式会社 Non-invasive drug delivery system for posterior ocular tissue using solid composition
ES2603057T3 (en) * 2009-10-30 2017-02-23 Aton Pharma, Inc. Ocular drug delivery devices
BE1030504B1 (en) 2022-05-06 2023-12-04 Eyed Pharma COMPOSITE INSERT FOR THE TREATMENT OF DRY EYE
WO2023214027A1 (en) 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
BE1030503B1 (en) 2022-05-06 2023-12-04 Eyed Pharma INSERT FOR THE TREATMENT OF DRY EYE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same

Also Published As

Publication number Publication date
FI58433C (en) 1981-02-10
CH609864A5 (en) 1979-03-30
DE2462081C3 (en) 1980-04-03
DD117349A5 (en) 1976-01-12
HU171803B (en) 1978-03-28
CA1063022A (en) 1979-09-25
AU509331B2 (en) 1980-05-08
NL7415883A (en) 1975-06-19
PH17250A (en) 1984-07-03
IT1056094B (en) 1982-01-30
JPS50105814A (en) 1975-08-20
AU7623574A (en) 1976-06-10
DE2459391C3 (en) 1978-10-19
JPS5636173B2 (en) 1981-08-22
DE2462081B2 (en) 1979-08-02
NO744394L (en) 1975-07-14
EG11698A (en) 1977-10-31
DE2459391B2 (en) 1978-02-09
IL46209A (en) 1978-03-10
FI58433B (en) 1980-10-31
GB1485149A (en) 1977-09-08
LU71490A1 (en) 1975-08-20
DD121643A5 (en) 1976-08-12
DK137946C (en) 1978-12-11
IE40466B1 (en) 1979-06-06
ES432866A1 (en) 1977-02-16
IL46209A0 (en) 1975-03-13
AT333945B (en) 1976-12-27
HK30880A (en) 1980-06-13
SE7415248L (en) 1975-06-18
PH10938A (en) 1977-10-05
IE40466L (en) 1975-06-17
DK629774A (en) 1975-08-25
FI352274A (en) 1975-06-18
FR2254350A1 (en) 1975-07-11
DK137946B (en) 1978-06-12
NL167326B (en) 1981-07-16
ATA996174A (en) 1976-04-15
DE2459391A1 (en) 1975-06-19
DE2462081A1 (en) 1975-11-06
NO140489B (en) 1979-06-05
NO140489C (en) 1979-09-19
CH611797A5 (en) 1979-06-29
RO63070A (en) 1978-06-15
GB1485150A (en) 1977-09-08
SE408014B (en) 1979-05-14
KE3049A (en) 1980-06-06
FR2254350B1 (en) 1978-07-21
NL167326C (en) 1981-12-16

Similar Documents

Publication Publication Date Title
CA1021478A (en) Waste treatment process
IL44030A (en) Imidazolymethyl and thiazolylmethyl sulphoxides and process for their preparation
ES432866A1 (en) Ophthalmic inserts
HU174479B (en) Process for producing n-phosphono-methylglycine derivatives, and fitotoxic compositions containing them as active agents
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
IL45309A (en) Tetrahydroacridones,process for preparing them and pharmaceutical compositions containing them
ES432848A2 (en) Alkanolamine derivatives
CA1012374A (en) Machine for the treatment of fabrics
CA1029746A (en) Process for preparing derivatives of benzene fluorinated in the lateral chains
ES422694A1 (en) 1-Benzal-1,2,3,4-tetrahydro-isoquinolinium-theophylline-7-acetates
ES423580A1 (en) Diphenylpropylamines
YU259174A (en) Process for the manufacture of low -smoking gun-powder in the form of cord
AU6494374A (en) Method and compositions for the treatment of dermatomycosis
ES454760A1 (en) Process for manufacturing 2-stilbenyl-1,2,3-triazoles and new 2-stilbenyl-1,2,3-triazoles
AU485405B2 (en) Treatment tank for textile materials
CA813317A (en) Belt type electrolytic grinding machine
AU6640674A (en) Treatment tank for textile materials
ZA747361B (en) New method of treatment of sugar-cane
GB1269969A (en) ETHYL 10 (beta-N-MORPHOLINYLPROPIONYL)-PHENTHIAZINE-2-CARBAMATE AND THE HYDROCHLORIDE THEREOF AND A METHOD FOR PREPARING THE SAME
CA843956A (en) Process for the production of tetrahydro-1,3,5-thiadiazine-2-thiones and their use as microbicides
CA843955A (en) Process for the production of tetrahydro-1, 3,5-thiadiazine-2-thiones and their use as microbicides
ZA731692B (en) Improvements in the treatment of soil
CA806186A (en) Process for preparing tetrahydro-1,3,5-thiadiazine-2-thiones
AU63949S (en) Eye goggles
AU489487B2 (en) Improvements in or relating tothe treatment of minerals

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202